Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 9, 2014, Pages

  Li, Hui ^a   Wang, Jijun ^a   Li, Chunbo ^a   Xiao, Zeping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE EVENT; DORSOLATERAL PREFRONTAL CORTEX; ELECTROCONVULSIVE THERAPY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MONOTHERAPY; OUTCOME ASSESSMENT; PANIC; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; REVIEW; RISK ASSESSMENT; SAMPLE SIZE; SENSITIVITY ANALYSIS; SYMPTOM; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT RESPONSE; ADVERSE EFFECTS; PANIC DISORDER; PATIENT DROPOUTS; PREFRONTAL CORTEX; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; HUMANS; PANIC DISORDER; PATIENT DROPOUTS; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84922773354     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009083.pub2     Document Type: Review

References (76)

1. Mantovani A. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. http://clinicaltrials.gov/ct2/show/NCT00521352 2007 (accessed August 2012).
2. Mantovani A, Aly M, Dagan W, Allart A, Lisanby SH. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. Journal of Affective Disorders 2013;144(1-2):153-9.
3. Prasko J, Bares M, Horacek J, Kopecek M, Novak T, Paskova B, et al.Efficacy of rTMS in panic disorder noresponders to SSRI. Psychiatrie 2009;13 Suppl 2:103-4.
4. Prasko J, Zalesky R, Bares M, Horacek J, Kopecek M, Novak T, et al.The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: A randomized, double blind sham controlled study. Neuroendocrinology Letters 2007;28(1):33-8.
5. Hao HJ, Wang XY. Clinical effect of repeat transcranial magnetic stimulation of electric acupuncture combined with drug in treating anxiety disease [Chinese Source]. 2011;28(02):125-7.
6. Mantovani A, Lisanby SH, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. Journal of Affective Disorders 2007;102(1-3):277-80. [PUBMED: 17215046]
7. Wang J. Buspirone combined repetitive transcranial magnetic stimulation (rTMS) for anxiety disorder [Chinese Source]. Medical Joumal of Chinese Peoples Health 2013;3:65-6.
8. Deppermann S, Vennewald N, Haeussinger FB, Sickinger S, Ehlis A-C, Fallgatter AJ, et al.Repetitive transcranial magnetic stimulation (RTMS) as a new supportive tool in the therapy of panic disorder?. European Psychiatry 2013;8 Suppl 1:1631.
9. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200. [: OLZ020600]
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington DC: American Psychiatric Association, 1994.
11. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985; Vol. 1, issue 8437:1106-7. [PUBMED: 2860322]
12. Berkowitz RL, Coplan JD, Reddy DP, Gorman JM. The human dimension: how the prefrontal cortex modulates the subcortical fear response. Reviews in the Neurosciences 2007;18(3-4):191-207. [PUBMED: 18019606]
13. Bland JM, Kerry SM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
14. Crost NW, Pauls CA, Wacker J. Defensiveness and anxiety predict frontal EEG asymmetry only in specific situational contexts. Biological Psychology 2008;78(1):43-52. [PUBMED: 18295958]
15. D'Alfonso AA, Van Honk J, Hermans E, Postma A, De Haan EH. Laterality effects in selective attention to threat after repetitive transcranial magnetic stimulation at the prefrontal cortex in female subjects. Neuroscience Letters 2000;280(3):195-8. [PUBMED: 10675794]
16. Davidson RJ, Marshall JR, Tomarken AJ, Henriques JB. While a phobic waits: regional brain electrical and autonomic activity in social phobics during anticipation of public speaking. Biological Psychiatry 2000;47(2):85-95. [PUBMED: 10664824]
17. De Carvalho MR, Dias GP, Cosci F, De-Melo-Neto VL, Bevilaqua MC, Gardino PF, et al.Current findings of fMRI in panic disorder: contributions for the fear neurocircuitry and CBT effects. Expert Review of Neurotherapeutics 2010;10(2):291-303. [PUBMED: 20136384]
18. Depping AM, Komossa K, KisslingW, Leucht S. Second-generation antipsychotics for anxiety disorders. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD008120.pub2]
19. Di Lazzaro V, Pilato F, Saturno E, Oliviero A, Dileone M, Mazzone P, et al.Theta-burst repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortex. The Journal of Physiology 2005;565(Pt 3):945-50. [PUBMED: 15845575]
20. Divine GW, Brown JT, Frazer LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7:623-9.
21. Dresler T, Ehlis AC, Plichta MM, Richter MM, Jabs B, Lesch KP, et al.Panic disorder and a possible treatment approach by means of high-frequency rTMS: a case report. The World Journal of Biological Psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 3):991-7. [PUBMED: 19396702]
22. Edwards MJ, Talelli P, Rothwell JC. Clinical applications of transcranial magnetic stimulation in patients with movement disorders. Lancet Neurology 2008;7(9):827-40. [PUBMED: 18703005]
23. Fitzgerald PB, Daskalakis ZJ. A practical guide to the use of repetitive transcranial magnetic stimulation in the treatment of depression. Brain Stimulation 2012;5(3):287-96.
24. Furukawa TA, Watanabe N, Churchill R. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD004364.pub2]
25. Garcia-Toro M, Salva Coll J, Crespi Font M, Andres Tauler J, Aguirre Orue I, Bosch Calero C. Panic disorder and transcranial magnetic stimulation [Trastorno de angustia estimulacion magnetica transcraneal.]. Actas Espanolas de Psiquiatria 2002;30(4):221-4. [PUBMED: 12217271]
26. George MS, Padberg F, Schlaepfer TE, O'Reardon JP, Fitzgerald PB, Nahas ZH, et al.Controversy: Repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessive-complusive disorder, panic, posttraumatic stress disorder). Brain Stimulation 2009;2(1):14-21.
27. George MS, Taylor JJ, Short EB. The expanding evidence base for rTMS treatment of depression. Current Opinion in Psychiatry 2013;26(1):13-8.
28. Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith S, et al.The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry 2006;67(3):363-74. [PUBMED: 16649821]
29. Guaiana G, Mortimer AM, Robertson C. Efficacy of transcranial magnetic stimulation in panic disorder: a case report. The Australian and New Zealand Journal of Psychiatry 2005; Vol. 39, issue 11-2:1047. [PUBMED: 16343310]
30. Guaiana G, Barbui C, Chiodo D, Cipriani A, Davies SJC, Koesters M. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD010677]
31. Guaiana G, Barbui C, Chiodo D, Cipriani A, Davies SJC, Koesters M. Antidepressants versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD010676]
32. Guaiana G, Barbui C, Chiodo D, Cipriani A, Davies SJC, Imai H, et al.Azapirones versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD010828]
33. Gulliford MC, Ukoumunne OC, Chinn S. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-83.
34. Guy W. ECDEU Assessment manual for psychopharmacology. Rockville, U.S. DHEW, 1976.
35. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960;23:56-62.
36. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959;32:50-5.
37. Haraldsson HM, Ferrarelli F, Kalin NH, Tononi G. Transcranial magnetic stimulation in the investigation and treatment of schizophrenia: a review. Schizophrenia Research 2004;71(1):1-16. [PUBMED: 15374567]
38. Heldt E, Manfro GG, Kipper L, Blaya C, Maltz S, Isolan L, et al.Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital. Psychotherapy and Psychosomatics 2003;72(1):43-8. [PUBMED: 12466637]
39. Higgins JP, White IR, Anzures-Cabrera J. Meta-analysis of skewed data: combining results reported on log-transformed or raw scales. Statistics in Medicine 2008;27(29):6072-92. [PUBMED: 18800342]
40. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
41. Hollander E, Simeon D. Anxiety Disorders. The American Psychiatric PublishingTextbook of Psychiatry (5th edition). American Psychiatric Publishing Inc. Washington, DC, 2008:505-608.
42. Holt RL, Lydiard RB. Management of treatment-resistant panic disorder. Psychiatry 2007;4(10):48-59. [PUBMED: 20428311]
43. Imai H, Tajika A, Chen P, Pompoli A, Furukawa TA. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. Cochrane Database of Systematic Reviews 2014, Issue 7. [DOI: 10.1002/14651858.CD011170]
44. Kanno M, Matsumoto M, Togashi H, Yoshioka M, Mano Y. Effects of repetitive transcranial magnetic stimulation on behavioral and neurochemical changes in rats during an elevated plus-maze test. Journal of the Neurological Sciences 2003;211(1-2):5-14. [PUBMED: 12767491]
45. Kinley DJ, Cox BJ, Clara I, Goodwin RD, Sareen J. Panic attacks and their relation to psychological and physical functioning in Canadians: results from a nationally representative sample. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2009;54(2):113-22. [PUBMED: 19254442]
46. Li X, Nahas Z, Kozel FA, Anderson B, Bohning DE, George MS. Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biological Psychiatry 2004;55(9):882-90. [PUBMED: 15110731]
47. Machado S, Paes F, Velasques B, Teixeira S, Piedade R. Is rTMS an effective therapeutic strategy that can be used to treat anxiety disorders?. Neuropharmacology 2012;62:125-34.
48. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. The British Journal of Psychiatry 2000;176:249-52.
49. McHugh RK, Smits JAJ, Otto MW. Empirically supported treatment for panic disorder. Medical Clinics of North America 2009;32:593-610.
50. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. The British Journal of Psychiatry 1979;134:382-9. [PUBMED: 444788]
51. Paes F, Machado S, Arias-Carrión O, Velasques B, Teixeira S, Budde H, et al.The value of repetitive transcranial magnetic stimulation (rTMS) for the treatment of anxiety disorders: an integrative review. CNS & Neurological Disorders - Drug Targets 2011;10(5):610-20.
52. Pal PK, Hanajima R, Gunraj CA, Li JY, Wagle-Shukla A, Morgante F, et al.Effect of low-frequency repetitive transcranial magnetic stimulation on interhemispheric inhibition. Journal of Neurophysiology 2005;94(3):1668-75. [PUBMED: 15872061]
53. Pallanti S, Bernardi S. Neurobiology of repeated transcranial magnetic stimulation in the treatment of anxiety: a critical review. International Clinical Psychopharmacology 2009;24(4):163-73. [PUBMED: 19455047]
54. Pigot M, Loo C, Sachdev P. Repetitive transcranial magnetic stimulation as treatment for anxiety disorders. Expert Review of Neurotherapeutics 2008;8(10):1449-55.
55. Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G. Psychological therapies for panic disorder with or without agoraphobia in adults. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD011004]
56. Prasko J, Horacek J, Zalesky R, Kopecek M, Novak T, Paskova B, et al.The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuroendocrinology Letters 2004;25(5):340-8. [PUBMED: 15580167]
57. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Review Manager (RevMan), 2012.
58. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology 2009;120(12):2008-39. [PUBMED: 19833552]
59. Roy-Byrne PP, Craske MG, Stein MB. Panic disorder. Lancet 2006;368:1023-32.
60. Sakkas P, Psarros C, Papadimitriou GN, Theleritis CG, Soldatos CR. Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006;30(5):960-2. [PUBMED: 16631291]
61. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet 2002;359(9305):515-9. [PUBMED: 11853818]
62. Schulz KF, Grimes DA. Unequal group sizes in randomised trials: guarding against guessing. Lancet 2002;359(9310):966-70. [PUBMED: 11918933]
63. Schulz KF, Grimes DA. The Lancet Handbook of Essential Concepts in Clinical Research. Edinburgh (UK): Elsevier, 2006.
64. Schutter DJ, Van Honk J, D'Alfonso AA, Postma A, De Haan EH. Effects of slow rTMS at the right dorsolateral prefrontal cortex on EEG asymmetry and mood. Neuroreport 2001;12(3):445-7. [PUBMED: 11234743]
65. Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al.Multicenter collaborative panic disorder severity scale. The American Journal of Psychiatry 1997;154(11):1571-5. [PUBMED: 9356566]
66. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. International Clinical Psychopharmacology 1996;11 Suppl 3:89-95. [PUBMED: 8923116]
67. Sherbourne CD, Sullivan G, Craske MG, Roy-Byrne P, Golinelli D, Rose RD, et al.Functioning and disability levels in primary care out-patients with one or more anxiety disorders. Psychological Medicine 2010;11:1-10. [PUBMED: 20146834]
68. Van den Heuvel OA, Veltman DJ, Groenewegen HJ, Witter MP, Merkelbach J, Cath DC, et al.Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Archives of General Psychiatry 2005;62(8):922-33. [PUBMED: 16061770]
69. Vennewald N, Diemer J, Zwanzger P. Repetitive transcranial magnetic stimulation (rTMS) for anxiety disorders - A possible therapeutic option?: A systematic review. Fortschritte der Neurologie-Psychiatrie 2013;81(10):550-60.
70. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473-83. [PUBMED: 1593914]
71. Watanabe N, Churchill R, Furukawa TA. Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD005335.pub2]
72. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: World Health Organization, 1992.
73. Xia J, Adams C, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al.Losing participants before trial ends erodes credibility of finding. Psychiatric Bulletin 2009;33(7):254-7.
74. Xu BQ, Wang JJ, Li CB. Repetitive transcranial magnetic stimulation (rTMS) for anxiety disorder: A review [Chinese source]. Shanghai Archives of Psychiatry 2010;21(1):45-7.
75. Zwanzger P, Minov C, Ella R, Schule C, Baghai T, Moller HJ, et al.Transcranial magnetic stimulation for panic. The American Journal of Psychiatry 2002; Vol. 159, issue 2:315-6. [PUBMED: 11823280]
76. Zwanzger P, Fallgatter AJ, Zavorotnyy M, Padberg F. Anxiolytic effects of transcranial magnetic stimulation - an alternative treatment option in anxiety disorders?. Journal of Neural Transmission 2009;116(6):767-75.